Critical role of activation induced cytidine deaminase in Experimental Autoimmune Encephalomyelitis

References

• Sospedra M., Martin R.. Immunology of multiple sclerosis. Annual Rev. Immunol.. 2005; 23:683–747.
   PubMed Web of Science ®Google Scholar
• Townsend M. J., Monroe J. G., Chan A. C.. B-cell targeted therapies in human autoimmune diseases: An updated perspective. Immunol. Rev.. 2010; 237:264–283.
   PubMed Web of Science ®Google Scholar
• Lanzavecchia A.. Receptor-mediated antigen uptake and its effect on antigen presentation to class II-restricted T lymphocytes. Ann. Rev. Immunol.. 1990; 8:773–793.
   PubMed Web of Science ®Google Scholar
• Duddy M. E., Alter A., Bar-Or A.. Distinct profiles of human B cell effector cytokines: A role in immune regulation?. J. Immunol.. 2004; 172:3422–3427.
   PubMed Web of Science ®Google Scholar
• Matsushita T., Yanaba K., Bouaziz J. D., Fujimoto M., Tedder T. F.. Regulatory B cells inhibit EAE initiation in mice while other B cells promote disease progression. J. Clin. Invest.. 2008; 118:3420–3430.
   PubMed Web of Science ®Google Scholar
• Genain C. P., Nguyen M. H., Letvin N. L., . Antibody facilitation of multiple sclerosis-like lesions in a nonhuman primate. J. Clin. Invest.. 1995; 96:2966–2974.
   PubMedGoogle Scholar
• Linington C., Bradl M., Lassmann H., Brunner C., Vass K.. Augmentation of demyelination in rat acute allergic encephalomyelitis by circulating mouse monoclonal antibodies directed against a myelin/oligodendrocyte glycoprotein. Amer. J. Pathol.. 1988; 130:443–454.
   PubMed Web of Science ®Google Scholar
• Kerlero de Rosbo N., Honegger P., Lassmann H., Matthieu J. M.. Demyelination induced in aggregating brain cell cultures by a monoclonal antibody against myelin/oligodendrocyte glycoprotein. J. Neurochem.. 1990; 55:583–587.
   PubMed Web of Science ®Google Scholar
• Lyons J. A., Ramsbottom M. J., Cross A. H.. Critical role of antigen-specific antibody in experimental autoimmune encephalomyelitis induced by recombinant myelin oligodendrocyte glycoprotein. Euro. J. Immunol.. 2002; 32:1905–1913.
   PubMed Web of Science ®Google Scholar
• Marta C. B., Oliver A. R., Sweet R. A., Pfeiffer S. E., Ruddle N. H.. Pathogenic myelin oligodendrocyte glycoprotein antibodies recognize glycosylated epitopes and perturb oligodendrocyte physiology. Proc. Natl. Acad. Sci. USA. 2005; 102:13992–13997.
   PubMedGoogle Scholar
• Mason L. J., Ravirajan C. T., Latchman D. S., Isenberg D. A.. A human anti-dsDNA monoclonal antibody caused hyaline thrombi formation in kidneys of ‘leaky’ SCID mice. Clin. Exper. Immunol.. 2001; 126:137–142.
   PubMed Web of Science ®Google Scholar
• Kuerten S., Pauly R., Rottlaender A., . Myelin-reactive antibodies mediate the pathology of MBP-PLP fusion protein MP4-induced EAE. Clin. Immunol.. 2011; 140:54–62.
   PubMedGoogle Scholar
• Oliver A. R., Lyon G. M., Ruddle N. H.. Rat and human myelin oligodendrocyte glycoproteins induce experimental autoimmune encephalomyelitis by different mechanisms in C57BL/6 mice. J. Immunol.. 2003; 171:462–468.
   PubMed Web of Science ®Google Scholar
• Avasarala J. R., Cross A. H., Trotter J. L.. Oligoclonal band number as a marker for prognosis in multiple sclerosis. Arch. Neurol.. 2001; 58:2044–2045.
   PubMedGoogle Scholar
• Joseph F. G., Hirst C. L., Pickersgill T. P., . CSF oligoclonal band status informs prognosis in multiple sclerosis: a case control study of 100 patients. J. Neurol. Neurosurg. Psych.. 2009; 80:292–296.
   PubMed Web of Science ®Google Scholar
• Owens G. P., Bennett J. L., Lassmann H., . Antibodies produced by clonally expanded plasma cells in multiple sclerosis cerebrospinal fluid. Ann. Neurol.. 2009; 65:639–649.
   PubMed Web of Science ®Google Scholar
• Zhou D., Srivastava R., Nessler S., . Identification of a pathogenic antibody response to native myelin oligodendrocyte glycoprotein in multiple sclerosis. Proc. Natl. Acad. Sci. USA. 2006; 103:19057–19062.
   PubMed Web of Science ®Google Scholar
• O'Connor K. C., Appel H., Bregoli L., . Antibodies from inflamed central nervous system tissue recognize myelin oligodendrocyte glycoprotein. J. Immunol.. 2005; 175:1974–1982.
   PubMed Web of Science ®Google Scholar
• Hauser S. L., Waubant E., Arnold D. L., . B-cell depletion with rituximab in relapsing-remitting multiple sclerosis. New Engl. J. Med.. 2008; 358:676–688.
   PubMed Web of Science ®Google Scholar
• Muramatsu M., Kinoshita K., Fagarasan S., . Class switch recombination and hypermutation require activation-induced cytidine deaminase (AID), a potential RNA editing enzyme. Cell. 2000; 102:553–563.
   PubMed Web of Science ®Google Scholar
• Hackney J. A., Misaghi S., Senger K., . DNA targets of AID evolutionary link between antibody somatic hypermutation and class switch recombination. Adv. Immunol.. 2009; 101:163–189.
   PubMed Web of Science ®Google Scholar
• Humby F., Bombardieri M., Manzo A., . Ectopic lymphoid structures support ongoing production of class-switched autoantibodies in rheumatoid synovium. PLoS Med.. 2009; 6:e1.
   PubMed Web of Science ®Google Scholar
• Payne S. C., Chen P. G., Borish L.. Local class switching in nonallergic rhinitis. Curr. Opin. Otolaryngol. Head Neck Surg.. 2011; 19:193–198.
   PubMedGoogle Scholar
• Le Pottier L., Devauchelle V., Fautrel A., . Ectopic germinal centers are rare in Sjogren's syndrome salivary glands and do not exclude autoreactive B cells. J. Immunol.. 2009; 182:3540–3547.
   PubMed Web of Science ®Google Scholar
• Gu X., Shivarov V., Strout M. P.. The role of activation-induced cytidine deaminase in lymphomagenesis. Curr. Opin. Hematol.. 2012; 19:292–298.
   PubMed Web of Science ®Google Scholar
• Jiang C., Foley J., Clayton N., . Abrogation of lupus nephritis in activation-induced deaminase-deficient MRL/lpr mice. J. Immunol.. 2007; 178:7422–7431.
   PubMed Web of Science ®Google Scholar
• Jiang C., Zhao M. L., Diaz M.. Activation-induced deaminase heterozygous MRL/lpr mice are delayed in the production of high-affinity pathogenic antibodies and in the development of lupus nephritis. Immunology. 2009; 126:102–113.
   PubMed Web of Science ®Google Scholar
• Hsu H. C., Yang P., Wang J., . Interleukin 17-producing T helper cells and interleukin 17 orchestrate autoreactive germinal center development in autoimmune BXD2 mice. Nature Immunol.. 2008; 9:166–175.
   PubMed Web of Science ®Google Scholar
• Hsu H. C., Wu Y., Yang P., . Overexpression of activation-induced cytidine deaminase in B cells is associated with production of highly pathogenic autoantibodies. J. Immunol.. 2007; 178:5357–5365.
   PubMed Web of Science ®Google Scholar
• Weissert R.. Experimental Autoimmune Encephalomyelitis—Models, Disease Biology and Experimental Therapy. InTech. 2012.
   Google Scholar
• Warming S., Rachel R. A., Jenkins N. A., Copeland N. G.. Zfp423 is required for normal cerebellar development. Molecular and cellular biology. 2006; 26:6913–6922.
   PubMedGoogle Scholar
• Liu P., Jenkins N. A., Copeland N. G.. A highly efficient recombineering-based method for generating conditional knockout mutations. Genome Res.. 2003; 13:476–484.
   PubMed Web of Science ®Google Scholar
• Lee E. C., Yu D., Martinez de Velasco J., . A highly efficient Escherichia coli-based chromosome engineering system adapted for recombinogenic targeting and subcloning of BAC DNA. Genomics. 2001; 73:56–65.
   PubMed Web of Science ®Google Scholar
• Warming S., Costantino N., Court D. L., Jenkins N. A., Copeland N. G.. Simple and highly efficient BAC recombineering using galK selection. Nucl. Acids Res.. 2005; 33:e36.
   PubMed Web of Science ®Google Scholar
• Bettadapura J., Menon K. K., Moritz S., Liu J., Bernard C. C.. Expression, purification, and encephalitogenicity of recombinant human myelin oligodendrocyte glycoprotein. J. Neurochem.. 1998; 70:1593–1599.
   PubMedGoogle Scholar
• Linares D., Echevarria I., Mana P.. Single-step purification and refolding of recombinant mouse and human myelin oligodendrocyte glycoprotein and induction of EAE in mice. Protein Express. Purif.. 2004; 34:249–256.
   PubMedGoogle Scholar
• DeVoss J., Hou Y., Johannes K., . Spontaneous autoimmunity prevented by thymic expression of a single self-antigen. J. Exper. Med.. 2006; 203:2727–2735.
   PubMed Web of Science ®Google Scholar
• Misaghi S., Garris C. S., Sun Y., . Increased targeting of donor switch region and IgE in Sγ1-deficient B cells. J. Immunol.. 2010; 185:166–173.
   PubMedGoogle Scholar
• Stefferl A., Brehm U., Storch M., . Myelin oligodendrocyte glycoprotein induces experimental autoimmune encephalomyelitis in the “resistant” Brown Norway rat: disease susceptibility is determined by MHC and MHC-linked effects on the B cell response. J. Immunol.. 1999; 163:40–49.
   PubMed Web of Science ®Google Scholar
• Clements C. S., Reid H. H., Beddoe T., . The crystal structure of myelin oligodendrocyte glycoprotein, a key autoantigen in multiple sclerosis. Proc. Natl. Acad. Sci. USA. 2003; 100:11059–11064.
   PubMed Web of Science ®Google Scholar
• Breithaupt C., Schubart A., Zander H., . Structural insights into the antigenicity of myelin oligodendrocyte glycoprotein. Proc. Natl. Acad. Sci. USA. 2003; 100:9446–9451.
   PubMed Web of Science ®Google Scholar
• Lyons J. A., San M., Happ M. P., Cross A. H.. B cells are critical to induction of experimental allergic encephalomyelitis by protein but not by a short encephalitogenic peptide. Euro. J. Immunol.. 1999; 29:3432–3439.
   PubMed Web of Science ®Google Scholar
• Svensson L., Abdul-Majid K. B., Bauer J., . A comparative analysis of B cell-mediated myelin oligodendrocyte glycoprotein-experimental autoimmune encephalomyelitis pathogenesis in B cell-deficient mice reveals an effect on demyelination. Euro. J. Immunol.. 2002; 32:1939–1946.
   PubMed Web of Science ®Google Scholar
• Komiyama Y., Nakae S., Matsuki T., . IL-17 plays an important role in the development of experimental autoimmune encephalomyelitis. J. Immunol.. 2006; 177:566–573.
   PubMed Web of Science ®Google Scholar
• Litzenburger T., Fassler R., Bauer J., . B lymphocytes producing demyelinating autoantibodies: development and function in gene-targeted transgenic mice. J. Exper. Med.. 1998; 188:169–180.
   PubMedGoogle Scholar
• Kitamura D., Roes J., Kuhn R., Rajewsky K.. A B cell-deficient mouse by targeted disruption of the membrane exon of the immunoglobulin mu chain gene. Nature. 1991; 350:423–426.
   PubMed Web of Science ®Google Scholar
• Trotter J., DeJong L. J., Smith M. E.. Opsonization with antimyelin antibody increases the uptake and intracellular metabolism of myelin in inflammatory macrophages. J. Neurochem.. 1986; 47:779–789.
   PubMedGoogle Scholar
• Matsushita S., Suzuki K., Murayama M., . Serotonin transporter regulatory region polymorphism is associated with anorexia nervosa. American journal of medical genetics. Pt. B, Neuropsych. Genet.. 2004; 128B:114–117.
   PubMed Web of Science ®Google Scholar
• Gaipl U. S., Kuhn A., Sheriff A., . Clearance of apoptotic cells in human SLE. Curr. Direct. Autoimmun.. 2006; 9:173–187.
   PubMedGoogle Scholar
• Ehrenstein M. R., Cook H. T., Neuberger M. S.. Deficiency in serum immunoglobulin (Ig)M predisposes to development of IgG autoantibodies. J. Exper. Med.. 2000; 191:1253–1258.
   PubMed Web of Science ®Google Scholar
• Ogden C. A., Kowalewski R., Peng Y., Montenegro V., Elkon K. B.. IGM is required for efficient complement mediated phagocytosis of apoptotic cells in vivo. Autoimmunity. 2005; 38:259–264.
   PubMed Web of Science ®Google Scholar
• Binder C. J., Silverman G. J.. Natural antibodies and the autoimmunity of atherosclerosis. Springer Semin. Immunopathol.. 2005; 26:385–404.
   PubMed Web of Science ®Google Scholar
• Werwitzke S., Trick D., Kamino K., . Inhibition of lupus disease by anti-double-stranded DNA antibodies of the IgM isotype in the (NZB × NZW)F1 mouse. Arthritis Rheumat.. 2005; 52:3629–3638.
   PubMed Web of Science ®Google Scholar
• Boes M., Schmidt T., Linkemann K., . Accelerated development of IgG autoantibodies and autoimmune disease in the absence of secreted IgM. Proc. Natl. Acad. Sci. USA. 2000; 97:1184–1189.
   PubMed Web of Science ®Google Scholar
• Hurez V., Kazatchkine M. D., Vassilev T., . Pooled normal human polyspecific IgM contains neutralizing anti-idiotypes to IgG autoantibodies of autoimmune patients and protects from experimental autoimmune disease. Blood. 1997; 90:4004–4013.
   PubMed Web of Science ®Google Scholar
• Bayry J., Negi V. S., Kaveri S. V.. Intravenous immunoglobulin therapy in rheumatic diseases. Nature Rev. Rheumatol.. 2011; 7:349–359.
   PubMed Web of Science ®Google Scholar
• Du C., Sriram S.. Increased severity of experimental allergic encephalomyelitis in lyn-/- mice in the absence of elevated proinflammatory cytokine response in the central nervous system. J. Immunol.. 2002; 168:3105–3112.
   PubMed Web of Science ®Google Scholar
• de Graaf K. L., Albert M., Weissert R.. Autoantigen conformation influences both B- and T-cell responses and encephalitogenicity. J. Biol. Chem.. 2012; 287:17206–17213.
   PubMedGoogle Scholar
• Slavin A. J., Soos J. M., Stuve O., . Requirement for endocytic antigen processing and influence of invariant chain and H-2M deficiencies in CNS autoimmunity. J. Clin. Invest.. 2001; 108:1133–1139.
   PubMedGoogle Scholar
• Hjelmstrom P., Juedes A. E., Fjell J., Ruddle N. H.. B-cell-deficient mice develop experimental allergic encephalomyelitis with demyelination after myelin oligodendrocyte glycoprotein sensitization. J. Immunol.. 1998; 161:4480–4483.
   PubMed Web of Science ®Google Scholar
• Sekiguchi Y., Ichikawa M., Takamoto M., . Antibodies to myelin oligodendrocyte glycoprotein are not involved in the severity of chronic non-remitting experimental autoimmune encephalomyelitis. Immunol. Lett.. 2009; 122:145–149.
   PubMedGoogle Scholar
• Martin F., Chan A. C.. B cell immunobiology in disease: evolving concepts from the clinic. Ann. Rev. Immunol.. 2006; 24:467–496.
   PubMed Web of Science ®Google Scholar